Compare AstraZeneca plc (AZN) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Manulife Financial Corporation — how do they compare? AstraZeneca plc trades at $158.15 (market cap $248.14B), while Manulife Financial Corporation trades at $43.84 (market cap $72.68B). The key difference: AstraZeneca plc is far larger — about 3.4× Manulife Financial Corporation's market cap, and Manulife Financial Corporation pays the higher dividend (3.1%). Which is the better fit depends on your goals.
| AZN | MFC | |
|---|---|---|
Market Cap | $248.14B | $72.68B |
Sector | Health | Financials |
52-Week High | $209.48 | $44.77 |
52-Week Low | $147.06 | $30.06 |
Enterprise Value | $275.41B | $67.84B |
Dividend Yield | 2.01% | 3.1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
